Quick Answer
IMMUNIC, INC. reported Net Income of -$97.17 million for fiscal year 2025.
IMMUNIC, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$97.17M | +3.3% |
| 2024 | -$100.51M | -7.4% |
| 2023 | -$93.61M | +22.3% |
| 2022 | -$120.41M | -29.5% |
| 2021 | -$92.94M | -111.2% |
| 2020 | -$44.02M | -26.0% |
| 2019 | -$34.93M | -202.7% |
| 2018 | -$11.54M | +77.8% |
| 2017 | -$52.08M | -27.1% |
| 2016 | -$40.97M | +21.2% |
| 2015 | -$52.02M | -9.1% |
| 2014 | -$47.67M | -45.7% |
| 2013 | -$32.72M | -388.3% |
| 2012 | -$6.70M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$25.58M | -5.0% | +4.6% |
| June 30, 2025 | -$26.82M | -25.4% | -5.3% |
| March 31, 2025 | -$25.47M | +13.9% | -4.5% |
| September 30, 2024 | -$24.37M | -7.0% | -14.0% |
| June 30, 2024 | -$21.38M | +10.9% | +27.7% |
| March 31, 2024 | -$29.58M | -17.1% | -29.9% |
| September 30, 2023 | -$22.77M | -7.3% | +5.1% |
| June 30, 2023 | -$24.00M | -9.6% | +5.0% |
- IMMUNIC, INC. showed an increase of +3.3% in Net Income compared to the prior fiscal year.
- Over the 2012–2025 period, IMMUNIC, INC.’s net income has declined by 1350.1% (from -$6.70 million to -$97.17 million).
- The most recent figure is from IMMUNIC, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: